This article reports on the findings related to the following objective: to assess clinical practice gaps and challenges experienced by pathologists involved in RET-altered lung and thyroid cancer care in Germany, Japan, the United Kingdom, and the United States. The gene discussed is RET; the disease is thyroid cancer.